Skip to content
ChickenStockChickenStock
ResearchCPRX
Catalyst Pharmaceuticals logo

Catalyst Pharmaceuticals (CPRX) stock

NASDAQ

Latest earnings

SEC filings

Jan–Mar 2026(FY2026 Q1)

Revenue increased 5.7% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed May 11, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Catalyst Pharmaceuticals (CPRX) stock information

NASDAQ

Catalyst Pharmaceuticals (CPRX) is listed on NASDAQ. These figures are computed in-house from official filings and are reference information only.

Catalyst Pharmaceuticals — frequently asked questions

Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.